FDA Grants QIDP Designation to Bayer’s Inhaled Drugs for Bronchiectasis and Pneumonia
News
Qualified infectious disease product (QIDP) designation has been granted by the U.S. Food and Drug Administration (FDA) to two agents from Bayer – Ciprofloxacin Dry Powder for Inhalation (DPI) and ... Read more